OPK


Stock Update (NYSE:OPK): FDA Accepts Opko Health Inc.’s New Drug Application for Rayaldee

Opko Health Inc. (NYSE:OPK) announced that the U.

TipRanks Uncovers Pattern in Insider Trading; Groundbreaking Results

Last week, there was a tremendous display of confidence in Opko Health Inc. (NYSE:OPK) when CEO Phillip Frost made several discretionary purchases on …

Stock Update (NYSE:OPK): Opko Health Inc.’s 4Kscore(R) Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection

Opko Health Inc. (NYSE:OPK) announced the decision of the National Comprehensive Cancer Network (NCCN) to include 4Kscore® as a recommended test in the 2015 NCCN …

Insider Buying News: Opko Health Inc., Athersys, Inc., Prospect Capital Corporation, Brown-Forman Corporation

Recently, various executives have taken part in insider buying activity for the stocks of Opko Health Inc. (NYSE:OPK), Athersys, Inc.

Stock Update (NYSE:OPK): OPKO to Present New Data at International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress

Opko Health Inc.(NYSE:OPK) announced that the company will present new data on its long-acting clotting Factor VIIa-CTP (MOD-5014) at the International Society on Thrombosis …

Stock Update (NYSE:OPK): Opko Health Inc. to Acquire Bio-Reference Laboratories

Opko Health Inc. (NYSE:OPK) and Bio-Reference Laboratories, Inc.

Stock Update (NYSE:OPK): Opko Health Inc. Announces Submission of Rayaldee(TM) New Drug Application to U.S. Food and Drug Administration

Opko Health Inc. (NYSE: OPK) announced that it has submitted a New Drug Application (NDA) for oral Rayaldee to the U.

Oppenheimer Weighs in on Biotech Stocks: Opko Health Inc. (OPK) & OvaScience Inc (OVAS)

Rohit Vanjani of Oppenheimer rates stocks in the biotechnology sector and is one of the top 25 analysts rated on TipRanks. Yesterday, Vanjani made …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts